Galapagos NV (GLPG) Stock Price

GLPGStock
$29.0420.78%52W
Market Cap
P/E5.02x
PEG Ratio
Div yield
Beta0.45

GLPG Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-33.35%
Price vs S&P 500 (4W)-2.81%
VGM Score67.29
P/E Ratio (Annual)5.02x

GLPG Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
2.61
2.61
2.61
2.61

Industry Peers — Pharmaceuticals(571)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
GLPGGalapagos NV
ABC$29.04
LLYEli Lilly & Co.DBB$1233.66
JNJJohnson & JohnsonDCB$273.14
ABBVABBVIE INC.DCB$265.79
MRKMerck & Co., Inc.DCA$156.45
NVSNovartis AGCCC$159.98
AZNAstraZeneca PLCCBC$169.66
NVONovo-Nordisk A/SBCC$48.66
ABTAbbott LaboratoriesCCB$116.13
PFEPfizer Inc.CDC$28.57
VRTXVertex Pharmaceuticals IncDCB$552.85

About Galapagos NV

Galapagos NV is a fully integrated biotechnology company developing medicines for oncology and immunology, with operations in Europe and the United States. Its pipeline includes CAR-T cell therapies for blood cancers and a TYK2 inhibitor for autoimmune diseases currently in Phase 2 development. The company generates the majority of its revenue from the United States market.